AltruBio: Funding, Investors & Team (Sep 2026)
AltruBio is a biopharmaceutical company that is dedicated to creating targeted antibody treatments for cancer and immune-related inflammatory conditions. It is a global company based in Delaware with its main office in the San Francisco Bay Area, California. AbGenomics, with roots in Taipei, Taiwan since 2000, focuses on developing innovative therapies for medical conditions with unmet needs. Their research team has established a strong platform for discovering and validating new antibody treatments. AbGenomics currently has multiple potential therapeutic antibodies in development for autoimmune diseases, pancreatic cancer, stomach cancer, colorectal cancer, ovarian cancer, lung cancer, and other solid tumors.
AltruBio has raised $288M across 2 funding rounds on record, the most recent a Series B of $225M announced in May 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
AltruBio Company Profile and Key Stats
Latest funding round on record: May 2024.
AltruBio Funding Rounds
AltruBio raised $63.0M in a Series A announced in Apr 2021.
3.1 years later, a Series B of $225M was announced in May 2024.
AltruBio Founders and Leadership Team
Contact details for the AltruBio team: 1 of 1 has an email address on file.
Start 14-day free trial →AltruBio Funding Compared to Other Biotechnology Startups
AltruBio's latest round of $225M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like AltruBio in Biotechnology and Los Altos
Companies Similar to AltruBio
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
AltruBio Funding FAQs
What does AltruBio do?
AltruBio is a biopharmaceutical company that is dedicated to creating targeted antibody treatments for cancer and immune-related inflammatory conditions. It is a global company based in Delaware with its main office in the San Francisco Bay Area, California. AbGenomics, with roots in Taipei, Taiwan since 2000, focuses on developing innovative therapies for medical conditions with unmet needs. Their research team has established a strong platform for discovering and validating new antibody treatments. AbGenomics currently has multiple potential therapeutic antibodies in development for autoimmune diseases, pancreatic cancer, stomach cancer, colorectal cancer, ovarian cancer, lung cancer, and other solid tumors.
How much funding has AltruBio raised?
AltruBio has raised $288M across 2 rounds on record. The most recent is a Series B of $225M announced in May 2024.
When did AltruBio last raise funding?
AltruBio's most recent funding round on record is a Series B of $225M, announced in May 2024.
Who founded AltruBio?
FundedIQ lists Judy Chou (Founder) at AltruBio.
Where is AltruBio headquartered?
AltruBio is based in Los Altos, California, United States.
How many employees does AltruBio have?
AltruBio is in the 11-50 employee band.
How does AltruBio's funding compare to other Biotechnology startups?
AltruBio's latest round of $225M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's AltruBio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for AltruBio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.